A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening

BACKGROUND: Prostate-specific antigen (PSA) has modest specificity for prostate cancer. A panel of four kallikrein markers (total, free, and intact PSA and kallikrein-related peptidase 2) is a highly accurate predictor of biopsy outcome. The clinical significance of biopsy-detectable cancers in men...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vickers, Andrew, Gupta, Amit, Savage, Caroline J., Pettersson, Kim, Dahlin, Anders, Bjartell, Anders, Manjer, Jonas, Scardino, Peter T., Ulmert, David, Lilja, Hans
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3035761/
https://ncbi.nlm.nih.gov/pubmed/21148123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-10-1003
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge